These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 32017280)
1. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA. Rathitharan G; Truong J; Tong J; McCluskey T; Meyer JH; Mizrahi R; Warsh J; Rusjan P; Kennedy JL; Houle S; Kish SJ; Boileau I Addict Biol; 2021 Jan; 26(1):e12876. PubMed ID: 32017280 [TBL] [Abstract][Full Text] [Related]
2. Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA. Suridjan I; Rusjan PM; Voineskos AN; Selvanathan T; Setiawan E; Strafella AP; Wilson AA; Meyer JH; Houle S; Mizrahi R Neuroimage; 2014 Jan; 84():868-75. PubMed ID: 24064066 [TBL] [Abstract][Full Text] [Related]
3. Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [ Hafizi S; Da Silva T; Gerritsen C; Kiang M; Bagby RM; Prce I; Wilson AA; Houle S; Rusjan PM; Mizrahi R Neuropsychopharmacology; 2017 Dec; 42(13):2474-2481. PubMed ID: 28604733 [TBL] [Abstract][Full Text] [Related]
4. Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [ Hafizi S; Tseng HH; Rao N; Selvanathan T; Kenk M; Bazinet RP; Suridjan I; Wilson AA; Meyer JH; Remington G; Houle S; Rusjan PM; Mizrahi R Am J Psychiatry; 2017 Feb; 174(2):118-124. PubMed ID: 27609240 [TBL] [Abstract][Full Text] [Related]
5. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Kenk M; Selvanathan T; Rao N; Suridjan I; Rusjan P; Remington G; Meyer JH; Wilson AA; Houle S; Mizrahi R Schizophr Bull; 2015 Jan; 41(1):85-93. PubMed ID: 25385788 [TBL] [Abstract][Full Text] [Related]
6. Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA. Suridjan I; Rusjan PM; Kenk M; Verhoeff NP; Voineskos AN; Rotenberg D; Wilson AA; Meyer JH; Houle S; Mizrahi R Synapse; 2014 Nov; 68(11):536-47. PubMed ID: 25043159 [TBL] [Abstract][Full Text] [Related]
7. Microglial activation in Parkinson's disease using [ Ghadery C; Koshimori Y; Coakeley S; Harris M; Rusjan P; Kim J; Houle S; Strafella AP J Neuroinflammation; 2017 Jan; 14(1):8. PubMed ID: 28086916 [TBL] [Abstract][Full Text] [Related]
8. Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA. Mizrahi R; Rusjan PM; Kennedy J; Pollock B; Mulsant B; Suridjan I; De Luca V; Wilson AA; Houle S J Cereb Blood Flow Metab; 2012 Jun; 32(6):968-72. PubMed ID: 22472607 [TBL] [Abstract][Full Text] [Related]
10. In vivo imaging translocator protein (TSPO) in autism spectrum disorder. Simpson D; Gharehgazlou A; Da Silva T; Labrie-Cleary C; Wilson AA; Meyer JH; Mizrahi R; Rusjan PM Neuropsychopharmacology; 2022 Jun; 47(7):1421-1427. PubMed ID: 35383319 [TBL] [Abstract][Full Text] [Related]
11. Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder. Li H; Sagar AP; Kéri S J Affect Disord; 2018 Dec; 241():305-310. PubMed ID: 30142589 [TBL] [Abstract][Full Text] [Related]
12. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. Setiawan E; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Rajkowska G; Suridjan I; Kennedy JL; Rekkas PV; Houle S; Meyer JH JAMA Psychiatry; 2015 Mar; 72(3):268-75. PubMed ID: 25629589 [TBL] [Abstract][Full Text] [Related]
13. Cocaine abuse in humans is not associated with increased microglial activation: an 18-kDa translocator protein positron emission tomography imaging study with [11C]PBR28. Narendran R; Lopresti BJ; Mason NS; Deuitch L; Paris J; Himes ML; Kodavali CV; Nimgaonkar VL J Neurosci; 2014 Jul; 34(30):9945-50. PubMed ID: 25057196 [TBL] [Abstract][Full Text] [Related]
14. In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA. Suridjan I; Pollock BG; Verhoeff NP; Voineskos AN; Chow T; Rusjan PM; Lobaugh NJ; Houle S; Mulsant BH; Mizrahi R Mol Psychiatry; 2015 Dec; 20(12):1579-87. PubMed ID: 25707397 [TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [ Tan Z; Haider A; Zhang S; Chen J; Wei J; Liao K; Li G; Wei H; Dong C; Ran W; Li Y; Li Y; Rong J; Li Y; Liang SH; Xu H; Wang L Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361 [TBL] [Abstract][Full Text] [Related]
16. Translocator protein (18kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy. Li H; Sagar AP; Kéri S Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():1-7. PubMed ID: 29269262 [TBL] [Abstract][Full Text] [Related]
18. Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study. Hafizi S; Da Silva T; Meyer JH; Kiang M; Houle S; Remington G; Prce I; Wilson AA; Rusjan PM; Sailasuta N; Mizrahi R Neuropsychopharmacology; 2018 Jul; 43(8):1700-1705. PubMed ID: 29748630 [TBL] [Abstract][Full Text] [Related]
19. Whole body biodistribution and radiation dosimetry in humans of a new PET ligand, [(18)F]-FEPPA, to image translocator protein (18 kDa). Mizrahi R; Rusjan PM; Vitcu I; Ng A; Wilson AA; Houle S; Bloomfield PM Mol Imaging Biol; 2013 Jun; 15(3):353-9. PubMed ID: 22895910 [TBL] [Abstract][Full Text] [Related]
20. Voxel-based imaging of translocator protein 18 kDa (TSPO) in high-resolution PET. Ko JH; Koshimori Y; Mizrahi R; Rusjan P; Wilson AA; Lang AE; Houle S; Strafella AP J Cereb Blood Flow Metab; 2013 Mar; 33(3):348-50. PubMed ID: 23281426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]